title: Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction.
abstract: Catestatin is a peptide which is a potent inhibitor of catecholamine secretion and played essential functions in the cardiovascular system. Previous research found that dramatic changes of catestatin were associated with hemodynamics in acute myocardial infarction (AMI) during the first week after the AMI symptoms onset, but whether catestatin is also involved in the pathophysiological progression after AMI and then a predictor for outcomes is not clear. The aim of this study is to determine the correlation of plasma catestatin levels at different time points and the prognosis of AMI. 100 participants recruited were all patients with AMI, all of who received successful primary percutaneous coronary intervention (PCI) within 12h from the AMI symptom onset in our center; the concentrations of plasma catestatin were evaluated from blood samples of those 100 participants. Subsequent 65 months' follow-up was performed after discharging to evaluate cardiac adverse events and the association between catestatin levels and prognosis of AMI was examined. We confirmed the dramatic change of catestatin concentrations in the first week of AMI, and the levels of catestatin on D3 were much higher in adverse events group than those in non-adverse events group (p<0.0001), but the ratio of D7/D3 was significantly lower. In addition, the Kaplan-Meier analysis showed that the groups in which the levels on D3 were higher (p<0.0001) and the ratios of D7/D3 were lower (p<0.0001), patients trended to be more susceptive to adverse events after AMI. Furthermore, according to the analysis, we surmised catestatin level on D3 as an appropriate predictor for outcomes in patients with AMI with good specificity as well as sensitivity. All of the evidence confirmed that catestatin plays an important role in the progress of AMI, and may act as a promising target for prognostic prediction.
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Dan
authors.initials: D
authors.lastname: Zhu
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Xie
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Xinyu
authors.initials: X
authors.lastname: Wang
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Liang
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Haiyi
authors.initials: H
authors.lastname: Yu
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Gao
mesh_terms: D000208:Acute Disease; D053379:Chromogranin A / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000175:diagnosis*; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis
chemical_list: D053379:Chromogranin A; D010446:Peptide Fragments; C109084:chromogranin A (344-364)
references.citation: Endocrinology. 2008 Oct;149(10):4780-93
references.pmid: 18535098
references.citation: Eur Heart J. 2009 Jan;30(1):25-32
references.pmid: 19028779
references.citation: Anatol J Cardiol. 2015 Jul;15(7):577-85
references.pmid: 25538000
references.citation: Cell Mol Neurobiol. 2010 Nov;30(8):1171-9
references.pmid: 21104119
references.citation: Cell Mol Life Sci. 2007 Nov;64(22):2863-86
references.pmid: 17717629
references.citation: Regul Pept. 2010 Nov 30;165(1):52-62
references.pmid: 20965217
references.citation: Eur Heart J. 1995 Jun;16(6):770-8
references.pmid: 7588920
references.citation: PLoS One. 2014;9(8):e102536
references.pmid: 25099124
references.citation: Regul Pept. 2010 Nov 30;165(1):63-70
references.pmid: 20655339
references.citation: Heart Rhythm. 2011 Mar;8(3):342-8
references.pmid: 21093611
references.citation: J Hypertens. 2002 Jul;20(7):1335-45
references.pmid: 12131530
references.citation: Biomarkers. 2011 Dec;16(8):691-7
references.pmid: 22050388
references.citation: J Biol Chem. 1999 Jan 29;274(5):2920-8
references.pmid: 9915830
references.citation: J Biol Chem. 2000 Jul 28;275(30):22905-15
references.pmid: 10781584
references.citation: Clin Exp Hypertens. 2010;32(5):278-87
references.pmid: 20662728
references.citation: Cardiology. 2003;100(1):23-8
references.pmid: 12975542
references.citation: J Neurosci. 2002 Jan 15;22(2):377-88
references.pmid: 11784782
references.citation: Pflugers Arch. 2013 Jul;465(7):1031-40
references.pmid: 23319164
references.citation: Eur Heart J. 2007 May;28(9):1117-27
references.pmid: 17389654
references.citation: Am J Med. 2003 Jan;114(1):25-30
references.pmid: 12543286
references.citation: Postgrad Med J. 2013 Apr;89(1050):193-6
references.pmid: 23223776
references.citation: Lancet. 1969 Mar 29;1(7596):635-41
references.pmid: 4179882
references.citation: Lancet. 2008 Aug 16;372(9638):570-84
references.pmid: 18707987
references.citation: Circulation. 2008 Nov 4;118(19):1915-9
references.pmid: 18981312
references.citation: Am Heart J. 1993 Nov;126(5):1068-76
references.pmid: 8237747
references.citation: Eur J Heart Fail. 2013 May;15(5):565-72
references.pmid: 23288914
references.citation: Regul Pept. 2003 Jun 15;114(1):29-35
references.pmid: 12763637
references.citation: J Am Coll Cardiol. 2004 Aug 4;44(3):671-719
references.pmid: 15358045
references.citation: J Clin Invest. 1997 Sep 15;100(6):1623-33
references.pmid: 9294131
references.citation: Peptides. 1998;19(7):1241-8
references.pmid: 9786174
references.citation: N Engl J Med. 1984 Sep 27;311(13):819-23
references.pmid: 6382011
references.citation: Mol Endocrinol. 2000 Oct;14(10):1525-35
references.pmid: 11043569